Author

A. D. Bowen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

L. Liu· 3 shared Q. Wang· 3 shared A. Gordon· 2 shared D. D. Ho· 2 shared J. Yu· 2 shared M. Wang· 2 shared R. Valdez· 2 shared S. Iketani· 2 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

L. Liu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster

Q. Wang, A. D. Bowen, A. R. Tam, R. Valdez, E. Stoneman, I. A. Mellis, A. Gordon, L. Liu, D. D. Ho

This study compares neutralizing antibody titers after bivalent and monovalent mRNA boosters and BA.5 breakthrough infection, finding no significant difference at one month but higher titers in breakthrough patients at three months.

bioRxiv · Feb 13, 2023 · PreprintMicrobiology

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

Q. Wang, S. Iketani, Z. Li, L. Liu, Y. Guo, Y. Huang, A. D. Bowen, M. Liu, M. Wang, J. Yu, R. Valdez, A. S. Lauring, Z. Sheng, H. H. Wang, A. Gordon, , D. D. Ho

This study shows that new SARS-CoV-2 BQ and XBB subvariants have significantly reduced neutralization by vaccines and monoclonal antibodies, suggesting a threat to current immunity.

bioRxiv · Nov 23, 2022Microbiology

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5

Q. Wang, Y. Guo, S. Iketani, Z. Li, H. Mohri, M. Wang, J. Yu, A. D. Bowen, J. Y. Chan, J. G. Shah, N. Nguyen, Z. Chen, K. Meyers, M. T. Yin, M. E. Sobieszczyk, , D. Ho

This study analyzes antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5, finding BA.4/5 shows greater resistance to neutralizing antibodies than BA.2.12.1.

bioRxiv · May 26, 2022Microbiology